ACGN Insider Trading Activity and SEC Form 4 Filings
ACGN insider trading summary
No open-market insider purchases or sales of Aceragen, Inc. (ACGN) have been reported on SEC Form 4 in the past 12 months.
Latest ACGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 10, 2023 | Maxine Gowen | Insider | Sell | $26 (51 @ $0.51) |
| Aug 10, 2023 | Vincent Milano | Insider | Sell | $2K (3,283 @ $0.53) |
| Jul 13, 2023 | Pillar Pharmaceuticals 6, L.P. | 10% Owner | Sell | $3K (2,213 @ $1.54) |
| Jul 13, 2023 | Pillar Invest Corp | 10% Owner | Sell | $3K (2,213 @ $1.54) |
| Jul 13, 2023 | Youssef El Zein | 10% Owner | Sell | $3K (2,213 @ $1.54) |
| Jul 13, 2023 | Pillar Partners Foundation, L.P. | 10% Owner | Sell | $3K (2,213 @ $1.54) |
| Jul 13, 2023 | Abude Umari | 10% Owner | Sell | $3K (2,213 @ $1.54) |
| Jul 12, 2023 | Pillar Partners Foundation, L.P. | 10% Owner | Sell | $6K (3,605 @ $1.58) |
| Jul 12, 2023 | Youssef El Zein | 10% Owner | Sell | $6K (3,605 @ $1.58) |
| Jul 12, 2023 | Pillar Pharmaceuticals 6, L.P. | 10% Owner | Sell | $6K (3,605 @ $1.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.